Search

New York: Fitch Ratings has issued the following commentary: Fitch Ratings has affirmed and subsequently withdrawn Pfizer, Inc.'s, Wyeth LLC's and Pharmacia Corp.'s (collectively, Pfizer) ratings, including their 'A' Issuer [...]

Byline: Julia Kollewe AstraZeneca forecast higher 2022 sales and lifted its annual dividend for the first time in a decade after beating fourth-quarter profit expectations, but warned the boost from [...]

New York City: Moody's Investors Service has issued the following news release: Moody's Investors Service (Moody's) has today assigned a B2 rating to the proposed notes issuance of Covis Finco [...]

New York City: Moody's Investors Srvice has issued the following news release: Moody's Investors Service (Moody's) has today affirmed AstraZeneca PLC's (AstraZeneca) A3 senior unsecured rating, its (P)A3 senior unsecured [...]

Byline: Laurie Kulikowski To view this article on the web, click here: http://www.thestreet.com/story/13344330/1/the-10-highest-dividend-health-care-stocks-are-not-all-buys.html Health care stocks have been among the strongest performers to date and in this low-interest environment, investors [...]

CHICAGO -- Fitch Ratings has assigned an 'A+' rating to Pfizer Inc.'s (Pfizer's) $4.5 billion notes offering. Fitch expects Pfizer to use the net proceeds for general corporate purposes, including [...]

CHICAGO -- Fitch Ratings has affirmed Bristol-Myers Squibb Co.'s (Bristol- Myers) Issuer Default Rating (IDR) at 'A-' and has revised the Rating Outlook to Negative from Stable. The rating action [...]

CHICAGO -- Fitch Ratings has assigned an 'A-' rating to Bristol-Myers Squibb Co.'s (Bristol Myers Squibb) proposed notes offering. Fitch expects the net proceeds from the issuance to be used [...]